术中氨甲环酸输注减少儿童保肢手术围手术期失血:双盲随机安慰剂对照试验
该双盲随机安慰剂对照试验纳入48例因股骨恶性肿瘤行瘤段切除与大假体重建保肢手术的18岁以下儿童和青少年,比较术中输注氨甲环酸与安慰剂的安全性和疗效。结果显示两组术中失血量与输血需求无显著差异,但氨甲环酸组术后第1天和出院时围手术期失血量及围手术期输血量显著减少,且无药物相关不良事件。
要点
- 术中氨甲环酸输注在儿童保肢手术中安全,无轻微或重大药物相关不良事件。
- 氨甲环酸组与安慰剂组术中失血量(p=0.0616)和输血需求(p=0.812)无显著差异。
- 氨甲环酸组术后第1天围手术期失血量(p=0.0144)、出院时围手术期失血量(p=0.0106)及围手术期输血量(p=0.023)显著减少。
核心结论
- 氨甲环酸可安全用于儿童和青少年保肢手术的术中输注,并显著减少围手术期失血量和输血需求。
研究设计与样本
- 双盲随机安慰剂对照试验,纳入48例因股骨恶性肿瘤行瘤段切除与大假体重建保肢手术的18岁以下儿童和青少年,随机分为氨甲环酸组和安慰剂组。
主要发现
- 共纳入48例参与者,平均年龄12.5±3.44岁(范围5至18岁),男女比例1.18,所有参与者均为埃及种族和族裔。
- 无轻微或重大药物相关不良事件。
- 两组术中失血量无显著差异(p=0.0616),输血需求无显著差异(p=0.812)。
- 术后第1天围手术期失血量有显著差异(p=0.0144),出院时围手术期失血量有显著差异(p=0.0106),围手术期输血有显著差异(p=0.023)。
关键数值与推荐
- 氨甲环酸组方案:术前负荷剂量10 mg/kg输注,随后以5 mg/kg/hr持续输注至手术结束;安慰剂组给予相同剂量但以生理盐水替代氨甲环酸。
- 采用血红蛋白平衡法计算术中及围手术期失血量,记录术后第1天和出院时的围手术期失血量以及术中、术后总输血量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limb-salvage surgery for malignant bone tumors can be associated with considerable perioperative blood loss. The aim of this randomized controlled trial was to assess the safety and efficacy of the intraoperative infusion of tranexamic acid (TXA) in children and adolescents undergoing limb-salvage surgery. METHODS: All participants were <18 years of age at the time of surgery and diagnosed with a malignant bone tumor of the femur that was treated with resection and reconstruction with a megaprosthesis. Exclusion criteria included anatomic locations other than the femur, reconstruction with a vascularized fibular graft, and a previous history of deep venous thrombosis, coagulopathy, or renal dysfunction. Participants were randomly allocated to either the TXA group (a preoperative loading dose infusion of 10 mg/kg of TXA followed by a continuous infusion of 5 mg/kg/hr until the end of surgery) or the placebo group (the same dosage but with TXA substituted with an infusion of normal saline solution). Intraoperative and perioperative blood loss were calculated with use of the hemoglobin balance method. Perioperative blood loss at postoperative day 1 and at discharge from the hospital were calculated. The total volumes of blood transfused intraoperatively and postoperatively were recorded. A statistical comparison between the groups was performed for blood loss and blood transfusion as well as for possible independent variables other than TXA, including age, body mass index, histopathologic diagnosis, tumor volume, preoperative hemoglobin level, type of resection, and the duration of surgery. RESULTS: A total of 48 participants, with a mean age of 12.5 ± 3.44 years (range, 5 to 18 years) and a male-to-female ratio of 1.18, were included. All participants were Egyptians by race and ethnicity. There were no minor or major drug-related adverse events. There was no significant difference between the groups with respect to intraoperative blood loss (p = 0.0616) or transfusion requirements (p = 0.812), but there was a significant difference in perioperative blood loss at postoperative day 1 (p = 0.0144) and at discharge from the hospital (p = 0.0106) and in perioperative blood transfusion (p = 0.023). CONCLUSIONS: TXA can be safely infused intraoperatively in children and adolescents undergoing limb-salvage surgery, and it contributes significantly to the reduction of perioperative blood loss and transfusion requirements. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
引用
- El Ghoneimy AM, Mahmoud Kotb TA, Rashad I, et al. Intraoperative Tranexamic Acid Infusion Reduces Perioperative Blood Loss in Pediatric Limb-Salvage Surgeries: A Double-Blinded Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2025. PMID: 39841811. doi:10.2106/JBJS.24.00261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。